Dream Pharma, Roche Korea starts strategic partnership

Published: 2013-09-12 06:58:00

Updated: 2013-09-12 06:58:00

Dream Pharma, an affiliated company of Hanwha Group, said Tuesday that it has started a strategic partnership with Roche Korea is a Korean subsidiary of F. Hoffmann-La Roche, a research-focused healthcare company headquartered in Basel, Switzerland.

Under the deal, Roche Korea will be in charge of selling Dream Pharma’s incrementally modified drugs (IMDs) - Bonviva tablets (sodium ibandronat...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.